Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1726 - 1750 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BI01
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261692 1575.887227 C74H133N3O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ02
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260293 1578.886893 C74H134N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF02
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260413 1578.886893 C74H134N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA02
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261629 1578.886893 C74H134N2O33
Gangliosides LMSP0601AK08
  • GD3(d18:1/26:1(17Z))
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262051 1581.949432 C78H139N3O29
Monoacylglycerophosphoinositolglycans LMGP15040048
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM6(19:2(9Z,12Z)/0:0)
126457705 1582.628768 C64H111O42P
Gangliosides LMSP0601AK06
  • GD3(d18:1/26:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262049 1583.965082 C78H141N3O29
Monoacylglycerophosphoinositolglycans LMGP15040047
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM6(19:1(9Z)/0:0)
126457704 1584.644418 C64H113O42P
Monoacylglycerophosphoinositolglycans LMGP15040046
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM6(19:0/0:0)
126457703 1586.660068 C64H115O42P
Gangliosides LMSP0601DD07
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262586 1586.928363 C77H138N2O31
Gangliosides LMSP0601DF07
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • KDN-GM1(d18:1/24:1(15Z))
44262602 1586.928363 C77H138N2O31
Gangliosides LMSP0601EB07
  • KDN-lactotetraosylceramide(d18:1/24:1(15Z))
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262762 1586.928363 C77H138N2O31
Gangliosides LMSP0601EC07
  • KDN(2-6)lactotetraosylceramide(d18:1/24:1(15Z))
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262770 1586.928363 C77H138N2O31
Gangliosides LMSP0601GE07
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263170 1586.928363 C77H138N2O31
Gangliosides LMSP0601GG07
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/24:1(15Z))
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263186 1586.928363 C77H138N2O31
Gangliosides LMSP0601DD05
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262584 1588.944013 C77H140N2O31
Gangliosides LMSP0601DF05
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • KDN-GM1(d18:1/24:0)
44262600 1588.944013 C77H140N2O31
Gangliosides LMSP0601EB05
  • KDN-lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262760 1588.944013 C77H140N2O31
Gangliosides LMSP0601EC05
  • KDN(2-6)lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262768 1588.944013 C77H140N2O31
Gangliosides LMSP0601GE05
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263168 1588.944013 C77H140N2O31
Gangliosides LMSP0601GG05
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/24:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263184 1588.944013 C77H140N2O31
Gangliosides LMSP0601BY03
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262366 1589.902877 C75H135N3O32
Gangliosides LMSP0601CJ03
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262438 1589.902877 C75H135N3O32
Gangliosides LMSP0601FF03
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262982 1589.902877 C75H135N3O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI03
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type IV H(d18:1/20:0)
44260230 1590.923278 C76H138N2O32

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024